Pintec Technology Holdings Limited - American Depositary Shares (PT)
1.0150
0.00 (0.00%)
Pintec Technology Holdings Ltd is a financial technology company that specializes in providing innovative technology solutions for the financial services industry
The company focuses on creating and optimizing digital finance platforms that connect consumers with lenders, enabling seamless access to credit and other financial products. Through its proprietary algorithms and data analytics capabilities, Pintec enhances the efficiency of lending processes and risk assessment, while also offering comprehensive support to both financial institutions and individuals. By leveraging its technological expertise, Pintec aims to drive digital transformation in the finance sector and improve accessibility to financial services.
With U.S. stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: Kadant Inc. (NYSE: KAI) announced plans to acquire Key Knife, Inc. for approximately $156 million in cash. Kadant shares fell 0.4% to close at $284.23 on Thursday.
Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit management.
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Gainers Laser Photonics Corporation (NASDAQ: LASE) shares rose 45% to $4.24 in pre-market trading. Laser Photonics announced that Coca-Cola recently completed the implementation of its first CleanTech Handheld Laser Blasting system in its manufacturing facilities.
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares jumped 52% to $2.1325 after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.
